These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 23836970

  • 1. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.
    Yawn BP, Li Y, Tian H, Zhang J, Arcona S, Kahler KH.
    Int J Chron Obstruct Pulmon Dis; 2013; 8():295-304. PubMed ID: 23836970
    [Abstract] [Full Text] [Related]

  • 2. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.
    Kew KM, Seniukovich A.
    Cochrane Database Syst Rev; 2014 Mar 10; 2014(3):CD010115. PubMed ID: 24615270
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
    Choi JH, Jeong KB, Park YH, Yu I, Lee SJ, Lee MK, Kim SH, Lee WY, Yong SJ, Lee JH.
    Int J Chron Obstruct Pulmon Dis; 2021 Mar 10; 16():3229-3237. PubMed ID: 34858023
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database.
    Miller DP, Watkins SE, Sampson T, Davis KJ.
    Int J Chron Obstruct Pulmon Dis; 2011 Mar 10; 6():467-76. PubMed ID: 22003292
    [Abstract] [Full Text] [Related]

  • 8. Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
    DiSantostefano RL, Sampson T, Le HV, Hinds D, Davis KJ, Bakerly ND.
    PLoS One; 2014 Mar 10; 9(5):e97149. PubMed ID: 24878543
    [Abstract] [Full Text] [Related]

  • 9. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
    Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A.
    Respir Res; 2018 Oct 05; 19(1):196. PubMed ID: 30290801
    [Abstract] [Full Text] [Related]

  • 10. Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD.
    Postma DS, Roche N, Colice G, Israel E, Martin RJ, van Aalderen WM, Grigg J, Burden A, Hillyer EV, von Ziegenweidt J, Gopalan G, Price D.
    Int J Chron Obstruct Pulmon Dis; 2014 Oct 05; 9():1163-86. PubMed ID: 25378918
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec 05; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 05; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL, Lin CH.
    Int J Chron Obstruct Pulmon Dis; 2016 Jun 05; 11():2341-2348. PubMed ID: 27703344
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan.
    Hirano R, Fujita M, Matsumoto T, On R, Watanabe K.
    Int J Chron Obstruct Pulmon Dis; 2018 Jun 05; 13():3503-3509. PubMed ID: 30498340
    [Abstract] [Full Text] [Related]

  • 20. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
    Crim C, Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Lettis S, Calverley PM.
    Ann Am Thorac Soc; 2015 Jan 05; 12(1):27-34. PubMed ID: 25490706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.